SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biofield may double within 3 months!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: damniseedemons who wrote (69)2/3/1997 1:53:00 AM
From: John Zwiener   of 120
 
Yes Sal, there is a little rising volume action that probably indicates a spike. But I want to see the study performed in Europe. The best info I've seen posted here was by richard luis, where montgomery securities said there was a 90% sensitivity and a 42-69% specificity.

The sensitivity apparently is for malignant and premalignant lesions. How is premalignant defined in this study? Probably 90% of "benign" growths can be associated with increased risk for later development of carcinoma. Are they calling these "premalignant"??? If they are, then there is something wrong here.

The specificity varies from 42-69%. Why? Did they breakdown how suspicious they were from test to test? Are they including these "premalignant" lesions again? Heck, even fibroadenomas are now recognized to be associated with increased risk. Ductal hyperplasia is associated with risk. Where do they draw the line.

There is talk of "when do sales start in Europe?". Well when is someone going to post the study? I assume there is some sort of approval in Europe so these studies should be public and available for us to look at. Without seeing how the study is constructed and how they interpret the results, this is pure speculation. If I could see the study, then I could have an opinion. From reading these posts, I really have little idea of what is going on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News